Plasma B-type natriuretic peptide levels in systolic heart failure

This publication has 27 references indexed in Scilit:

• Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
  Circulation, 2003
• Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
  New England Journal of Medicine, 2002
• ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
  Circulation, 2001
• Guidelines for the diagnosis and treatment of chronic heart failure
  European Heart Journal, 2001
• A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study
  Journal of the American College of Cardiology, 2001
• High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
  Journal of the American College of Cardiology, 2000
• Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
  The Lancet, 2000
• Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy
  Published by Oxford University Press (OUP) ,1999
• New Doppler echocardiographic applications for the study of diastolic function
  Journal of the American College of Cardiology, 1998
• Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern
  European Heart Journal, 1996